Patterns of Lymph Node Failure After Dose-Escalated Radiation Therapy in Patients Who Did Not Undergo Pelvic Lymph Node Irradiation: Implications for Extended Pelvic Lymph Node Coverage
Spratt, D.E.; Vargas, H.A.; Zumsteg, Z.S.; Pernicka, J. Golia; Osborne, J.; McBride, S.M.; Kollmeier, M.A.; Pei, X.; Zelefsky, M.J.
International Journal of Radiation Oncology*biology*physics 96(2): E239-E240
2016
ISSN/ISBN: 0360-3016
DOI: 10.1016/j.ijrobp.2016.06.1225
Accession: 064894609
PDF emailed within 0-6 h: $19.90
Related References
Spratt, D.E.; Vargas, H.A.; Zumsteg, Z.S.; Golia Pernicka, J.S.; Osborne, J.R.; Pei, X.; Zelefsky, M.J. 2017: Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage European urology 71(1): 37-43Fang, A.C.; Ahmad, A.E.; Whitson, J.M.; Ferrell, L.D.; Carroll, P.R.; Konety, B.R. 2010: Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer Cancer 116(8): 1901-1908
Passoni, N.M.; Bianchi, M.; Abdollah, F.; Gallina, A.; Suardi, N.; Matloob, R.; Tutolo, M.; Fossati, N.; Zanni, G.E.; Colombo, R.; Cozzarini, C.; Salonia, A.; Rigatti, P.; Montorsi, F.; Briganti, A. 2013: Head-To-Head Comparison of Lymph Node Density and Number of Positive Lymph Nodes in Stratifying the Outcome of Patients with Lymph Node Positive Prostate Cancer Submitted to Radical Prostatectomy and Extended Pelvic Lymph Node Dissection The Journal of Urology 189(4): e318-e319
Piura, B.; Rabinovich, A.; Friger, M. 2006: Number and distribution of pelvic lymph nodes and effect of surgical pathologic factors on pelvic lymph node status in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection European Journal of Gynaecological Oncology 27(5): 463-466
Leyh-Bannurah, S-Ramzi.; Budäus, L.; Zaffuto, E.; Pompe, R.S.; Bandini, M.; Briganti, A.; Montorsi, F.; Schiffmann, J.; Shariat, S.F.; Fisch, M.; Chun, F.; Huland, H.; Graefen, M.; Karakiewicz, P.I. 2018: Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification Urologic Oncology 36(2): 81.E17-81.E24
Mujezinović, F.; Takac, I. 2010: Pelvic lymph node dissection in early ovarian cancer: success of retrieval of lymph nodes by individual lymph node groups in respect to pelvic laterality European Journal of Obstetrics Gynecology and Reproductive Biology 151(2): 208-211
Lont, A.P.; Kroon, B.K.; Gallee, M.P.W.; van Tinteren, H.; Moonen, L.M.F.; Horenblas, S. 2007: Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival Journal of Urology 177(3): 947
Kridelka, F.J.; Berg, D.O.; Neuman, M.; Edwards, L.S.; Robertson, G.; Grant, P.T.; Hacker, N.F. 1999: Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study Cancer 86(10): 2059-2065
Cozzi, S.; Botti, A.; Timon, G.; Blandino, G.; Najafi, M.; Manicone, M.; Bardoscia, L.; Ruggieri, M.P.; Ciammella, P.; Iotti, C. 2022: Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer : An investigation of 117 pelvic lymph nodes Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 198(8): 700-709
Hinev, A.I.; Anakievski, D.; Kolev, N.H.; Hadjiev, V.I. 2014: Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection Urologia Internationalis 92(3): 300-305
Calleja, E.; Fowler, S.; McGrath, J.; Sooriakumaran, P.; Aning, J. 2017: Mp64-05 Contemporary Extended Pelvic Lymph Node Dissection for Prostate Cancer in the Uk - an Analysis of National Practice and Lymph Node Invasion Rates The Journal of Urology 197(4): e845-e846
Sood, A.; Keeley, J.; Palma-Zamora, I.; Dalela, D.; Arora, S.; Peabody, J.O.; Rogers, C.G.; Montorsi, F.; Menon, M.; Briganti, A.; Abdollah, F. 2020: Extended pelvic lymph-node dissection is independently associated with improved overall survival in patients with prostate cancer at high-risk of lymph-node invasion BJU international 125(6): 756-758
Heck, M.M.; Retz, M.; Bandur, M.; Souchay, M.; Vitzthum, E.; Weirich, G.; Schuster, T.; Autenrieth, M.; Kübler, H.; Maurer, T.; Thalgott, M.; Herkommer, K.; Gschwend, Jürgen.E.; Nawroth, R. 2018: Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 24(10): 2342-2349
Gacci, M.; Schiavina, R.; Lanciotti, M.; Masieri, L.; Serni, S.; Vagnoni, V.; Abdollah, F.; Carini, M.; Martorana, G.; Montorsi, F. 2013: External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection Urologia Internationalis 90(3): 277-282
Briganti, A.; Abdollah, F.; Nini, A.; Suardi, N.; Gallina, A.; Capitanio, U.; Bianchi, M.; Tutolo, M.; Passoni, Nò.Maria.; Salonia, A.; Colombo, R.; Freschi, M.; Rigatti, P.; Montorsi, F. 2012: Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection European Urology 61(6): 1132-1138